Pediatric Oncology

layoffs cut staff reduction workforce

Marketing

Y-mAbs' commercial chief exits, new hire asked to grow sales

Y-mAbs made the changes, which include “a small adjustment” to the commercial team, as part of a rethink that could put 13% of its team out of work.

Nick Paul Taylor Jan 13, 2025 8:35am

Ipsen

Ipsen secures ex-US rights to Day One's pediatric cancer med

Jul 25, 2024 10:05am

photo of a green light on a stoplight

US WorldMeds scores FDA approval in aggressive cancer

Dec 14, 2023 4:06pm